INTRODUCTION
Cap polyposis is a rare, benign colorectal condition characterized by multiple polyps covered with a thick layer of fibrinopurulent exudates. The diagnosis may be established during colonoscopy by typical colonoscopic findings. 1 The most commonly involved sites are the sigmoid colon and rectum, but the condition sometimes extends as far as the cecum. An optimal treatment for cap polyposis has not been established. Several alternative approaches, including anti-inflammatory agents, antibiotics, immunomodulators, and endoscopic therapy have been described. Surgical resection of the affected colon and rectum may be indicated for patients with persistent disease. Géhénot et al. 2 and Campbell et al. 3 reported a case of recurrence after surgery. Repeat surgery may be helpful in such cases, but there is no consensus regarding treatment for refractory cap polyposis. 4 Retroperitoneal fibrosis is a rare disease characterized by ureteral obstruction due to the presence of retroperitoneal tissue, consisting of chronic inflammation and marked fibrosis. 5 The pathogenesis of idiopathic retroperitoneal fibrosis is unclear. On the other hand, secondary retroperitoneal fibrosis may be caused by different factors. 6 Major abdominal surgeries, including colectomy, lymphadenectomy, and aortic aneurysmectomy are known to induce retroperitoneal fibrosis. 7, 8 We report a case of cap polyposis with retroperitoneal fibrosis after surgical treatment by low anterior resection. On retrograde pyelography, both ureters was medially displaced and narrowed. Bilateral double-J stent insertion was performed to resolve both hydronephroses. Colonoscopy revealed multiple, variable reddish sessile polyps with white fibrinopurulent exudates (Fig. 2) . Histolpathologic evaluation revealed hyperplastic glands without dysplasia and exudates of the mucosal surface (Fig. 3) .
The patient underwent laparoscopic retroperitoneal biopsy and adhesiolysis to exclude malignancy, resulting in a dif- weeks after the treatment (Fig. 5 ).
DISCUSSION
Cap polyposis, which was first described in 15 patients by Williams et al. 9 in 1985, is a benign colorectal condition characterized by multiple polyps covered with thick layer of fibrinopurulent exudates.
The pathogenesis is unclear. Local ischemia to the colonic mucosa due to abnormal colonic motility and repeated trauma caused by straining during defecation are important factors in the development of cap polyposis. 10 Inflammatory bowel diseases and infectious agents such as H. pylori or Escherichia coli 018 are also possible causes in the absence of abnormal colonic motility. 2, 11 Similar to the present case, Cap polyposis has been described following pelvic surgery. 17 reported a case of cap polyposis that was remarkably improved after a single infliximab infusion and did not recur for 3 years. Our patient underwent low anterior resection, and then developed symptomatic polyposis with bilateral ureteral obstruction due to retroperitoneal fibrosis.
Corticosteroids are the most useful drugs for the treatment of idiopathic retroperitoneal fibrosis. However, the optimal dose and duration of steroid therapy are not established.
In our patient, an initial daily dose of prednisolone 50 mg was administered. 18 This is the first report of cap polyposis with retroperitoneal fibrosis after surgery. Our patient's cap polyposis was much improved after 6 weeks. The present case of cap polyposis was benign and had a self-limiting course.
